Ascendis Pharma (ASND): OrbiMed Advisors Adds More Shares

Page 12 of 12

Page 12 of 12 – SEC Filing
EXHIBIT INDEX
Exhibit
Description
1.
Joint Filing Agreement among OrbiMed Advisors LLC, OrbiMed Capital GP V LLC and Samuel D. Isaly
2.
Registration Rights Agreement by and among the Issuer and each of the persons listed on Schedule A thereto, dated as of November 24, 2014 (incorporated by reference to Exhibit 10.6 to the Issuer’s Registration Statement on Form F-1 (SEC File No. 333-201050), filed with the SEC on December 18, 2014).
12

Follow Ascendis Pharma A/S

Page 12 of 12